|
Children's Oncology Group Phase 1 / Pilot Consortium
|
2U01CA097452-06
|
$2,573,434
|
$2,573,434
|
ADAMSON, PETER
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Functional analysis of signaling to and from p53 in ca
|
5R01CA098916-06
|
$258,227
|
$12,911
|
AGARWAL, Munna
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Epidemiologic Studies of Techa River Cohorts
|
N01CP045505-000
|
$102,671
|
$25,668
|
AKLEYEV, ALEXANDER
|
Urals Research Center for Radiation Mede
|
|
Studies of Occupational Cancer (Pesticides)
|
Z01 CP010119
|
$1,978,544
|
$202,072
|
Alavanja
|
DCEG (NCI)
|
|
SPORE in Lymphoma
|
3P50CA096888-05S1
|
$1,150,000
|
$862,500
|
AMBINDER, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Children's Oncology Group Statistics and Data Center
|
5U10CA098413-05
|
$5,859,839
|
$5,859,839
|
ANDERSON, JAMES
|
NATIONAL CHILDHOOD CANCER FOUNDATION
|
|
Mechanisms in Perinatal Carcinogenesis
|
Z01 BC 005352
|
$286,829
|
$286,829
|
Anderson, Lucy
|
CCR (NCI)
|
|
Descriptive Studies and Record Linkage
|
Z01 CP010183
|
$674,691
|
$44,322
|
Anderson
|
DCEG (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
Z01 SC 010378
|
$636,008
|
$318,004
|
Aplan, Peter
|
CCR (NCI)
|
|
Mechanisms of Chromosomal Translocation
|
Z01 SC 010379
|
$313,257
|
$125,303
|
Aplan, Peter
|
CCR (NCI)
|
|
GENETIC PREDICTORS OF LEUKEMIA THERAPY RESPONSE
|
5R01CA108862-03
|
$256,930
|
$256,930
|
Aplenc, Richard
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Mechanisms of PASG-Mediated Senescence in Hematopoietic Development and Leukemia
|
1R01CA120535-01A2
|
$311,600
|
$311,600
|
ARCECI, ROBERT
|
JOHNS HOPKINS UNIVERSITY
|
|
Significance of Bone Marrow Karyotypes in Patients with Inherited Bone Marrow Fai
|
Z01 BC 010692
|
$68,001
|
$13,600
|
Arthur, Diane
|
CCR (NCI)
|
|
Clinical Cancer Cytogenetics
|
Z01 BC 010694
|
$544,006
|
$136,002
|
Arthur, Diane
|
CCR (NCI)
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
3R01CA111419-02S1
|
$71,738
|
$71,738
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Role of Polyamines in MYCN-Amplified Neuroblastoma
|
5R01CA111419-02
|
$214,682
|
$214,682
|
BACHMANN, ANDRE
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Normal and Neoplastic Growth Regulation in the Brain
|
5P01CA096832-05
|
$1,770,072
|
$1,770,072
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Metabolic Syndrome Following Transplant for Leukemia
|
5R01CA112530-02
|
$420,764
|
$420,764
|
BAKER, KEVIN
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
|
Drug Development and Clinical Pharmacology of Anticancer Drugs for Childhood Canc
|
Z01 SC 006880
|
$1,453,500
|
$290,700
|
Balis, Frank
|
CCR (NCI)
|
|
Studies of the t(2;13) of alveolar rhabdomyosarcoma
|
5R01CA064202-14
|
$338,145
|
$338,145
|
BARR, FREDERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
COG studies of gene amplification in rhabdomyosarcoma
|
5R01CA104896-03
|
$413,715
|
$413,715
|
BARR, FREDERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Molecular Determinants of Methotrexate in ALL
|
5R01CA098152-05
|
$297,317
|
$297,317
|
BARREDO, JULIO
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Regional Oncology Research Center
|
3P30CA006973-45S1
|
$231,549
|
$9,262
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-45S2
|
$126,362
|
$5,054
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-45
|
$7,564,613
|
$302,585
|
BAYLIN, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Support Grant
|
5P30CA042014-20
|
$693,487
|
$13,870
|
Beckerle, Mary
|
UNIVERSITY OF UTAH
|
|
Provoking anti-tumor immune responses with Fas ligand
|
5R43CA119840-02
|
$335,358
|
$335,358
|
BELLGRAU, DONALD
|
APOPLOGIC PHARMACEUTICALS, LLC
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S1
|
$124,531
|
$8,717
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S3
|
$137,869
|
$9,651
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S4
|
$232,326
|
$16,263
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-43S5
|
$250,000
|
$17,500
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-43
|
$11,526,509
|
$806,856
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Geisinger Clinical Oncology Program
|
5U10CA035448-24
|
$458,852
|
$128,479
|
BERNATH, ALBERT
|
GEISINGER MEDICAL CENTER
|
|
Cancer Center Support Grant
|
3P30CA072720-11S1
|
$108,846
|
$1,088
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
3P30CA072720-11S2
|
$127,296
|
$1,273
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Cancer Center Support Grant
|
5P30CA072720-11
|
$3,128,377
|
$31,284
|
BERTINO, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
|
Z01 SC 004020
|
$1,324,087
|
$198,613
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Ethnic Differences in Survival after Childhood ALL
|
5R01CA096670-04
|
$485,753
|
$485,753
|
BHATIA, SMITA
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Genetic Consequences of Therapies for Cancer
|
5R01CA104666-03
|
$600,831
|
$600,831
|
BOICE, JOHN
|
VANDERBILT UNIVERSITY
|
|
Deficits in Facial Expression Recognition in Childhood Cancer Survivors
|
1R03CA128472-01
|
$92,338
|
$92,338
|
BONNER, MELANIE
|
DUKE UNIVERSITY
|
|
Minimal Residual Disease in Pediatric ALL in Relation to Other Prognostic Factors
|
5R01CA086011-07
|
$542,666
|
$542,666
|
BOROWITZ, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
The Pediatric Brain Tumor Consortium (PBTC)
|
5U01CA081457-09
|
$2,498,325
|
$2,498,325
|
BOYETT, JAMES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Role of TACI in B Cell Function and Transformation
|
5R01CA076274-10
|
$260,257
|
$130,129
|
BRAM, RICHARD
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$294
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Late Effects of Treatment in Wilms Tumor Survivors and Offspring
|
2R01CA054498-16
|
$1,027,469
|
$1,027,469
|
BRESLOW, NORMAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Neuroblastoma Biology and Therapy
|
5P01CA097323-05
|
$2,216,467
|
$2,216,467
|
BRODEUR, GARRETT
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
MHC Genetic Variation, Exposure to Infections and Risk of Childhood Leukemia
|
1R03CA125823-01A1
|
$60,215
|
$60,215
|
Buffler, Patricia
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Childhood Leukemia International Consortium (CLIC)
|
1R03CA132172-01
|
$62,413
|
$62,413
|
Buffler, Patricia
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Occupational Pesticide Exposure of Parents and Brain Tumor Risk in Children
|
1R03CA130028-01
|
$107,406
|
$53,703
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
CONTROL SELECTION METHODS FOR CHILDHOOD CANCER STUDIES
|
5R01CA108934-02
|
$374,780
|
$374,780
|
BUNIN, GRETA
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
Total relevant funding to Childhood Cancers for this search: $172,683,119
|